Influenza News and Research

Latest Influenza News and Research

Antibody response induced by mRNA vaccination differs from natural SARS-CoV-2 infection

Researchers tested the antibodies elicited from mRNA vaccination and compared them to those from natural SARS-CoV-2 infection. They found the vaccine did not have antibodies to the virus nucleocapsid protein but had potent RBD antibodies.

21 Apr 2021

Study identifies how SARS-CoV-2 enters and infects the brain

A recent preclinical study led by Anja Kipar of the University of Zurich and the University of Liverpool found evidence of the virus infecting and eventually provoking cell death in microglia and immune cells — but not neurons. The viral-induced apoptosis in these brain cells may explain why some long-haulers experience ‘brain fog’ months after recovery.

21 Apr 2021

Can an immunosuppressive cancer drug promote SARS-CoV-2 entry into host cells?

A new study shows that rapamycin, an immunosuppressive drug used in some cancers, and its analogs, may have an undesirable effect on viral entry into the host cells. This finding could inform their use to treat symptomatic COVID-19.

20 Apr 2021

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

A recent review in the International Journal of Biological Macromolecules provides a novel overview of 'virosome'-based nanovaccine production, its properties, and its application in viral diseases, emphasizing its importance in SARS-CoV-2 vaccine discovery.

20 Apr 2021

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.

19 Apr 2021

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

In a recent study posted to the medRxiv preprint server, a research group from Italy has demonstrated that the antibody response can be blunted in subjects with certain risk factors shortly after the second dose of mRNA vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Apr 2021

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.

17 Apr 2021

Elderly patients of female physicians are more likely to be vaccinated against the flu

New UCLA research suggests that elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu.

16 Apr 2021

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

A new study, released on the medRxiv* preprint server, examines the presence of SARS-CoV-2-specific IgA in human milk and its association with the protection of breastfed infants against the disease.

16 Apr 2021

Curcumin nanosystems could be powerful COVID-19 therapeutics

With new variants of SARS-CoV-2 emerging, the COVID-19 pandemic is far from over. While the global vaccine rollout has moved at an impressive speed, the search for new safe, effective, and targeted therapies is still on. Now, a new study reviews the potential for curcumin, a natural alkaloid derived from turmeric, and nanosystems to treat COVID-19.

16 Apr 2021

Obese or overweight patients at high risk for having worse COVID-19 outcomes

Patients who are overweight or obese have more severe COVID-19 and are highly likely to require invasive respiratory support, according to a new international study.

15 Apr 2021

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

The National Institutes of Health has awarded the University of Georgia a contract to establish the Center for Influenza Disease and Emergence Research.

15 Apr 2021

Researchers identify two distinct phenotypes of COVID-19-associated ARDS

Approximately one in four patients hospitalized for the acute respiratory distress syndrome (ARDS) associated with severe COVID-19 infections may have a distinct phenotype (disease presentation) or biochemical profile associated with organ dysfunction, blood-clotting abnormalities and greater risk of death than patients with other, seemingly similar forms of the disease, researchers at Massachusetts General Hospital have found.

15 Apr 2021

Study observes neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection

A new study by researchers at Oxford University examines neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection.

15 Apr 2021

Future attempts to reduce Covid-19 spread should focus on tackling airborne transmission

Any future attempts to reduce the spread of covid-19 should be focused on tackling close airborne transmission of the virus which is considered to be the primary route for its circulation, according to experts in an editorial published in The BMJ.

15 Apr 2021

Allometric model shows human travel is closely related to spread of COVID-19

A new study indicates that the spread of COVID-19 is governed by power-law dynamics, suggesting that alternative modeling approaches need to be used to understand and predict its propagation.

15 Apr 2021

NIAID establishes a network of research sites to study influenza outbreaks

he National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has established a network of research sites to study the natural history, transmission and pathogenesis of influenza and provide an international research infrastructure to address influenza outbreaks.

15 Apr 2021

SARS-CoV-2 mutations impact T-cell recognition of virus

A new research paper posted to the bioRxiv preprint server deals with the impact of these mutations on adaptive cellular immunity.

14 Apr 2021

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

The spike protein is the main part of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) responsible for the infection. It consists of two subunits S1 and S2. Upon entry of the virus into the human body, the S1 subunit helps the virus bind to the angiotensin-converting enzyme 2 (ACE2) receptors on host cells.

13 Apr 2021

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Researchers in South Africa and the UK have identified alpaca-derived nanoantibodies that potently neutralize variants of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

13 Apr 2021

Influenza News and Research

Latest Influenza News and Research

Antibody response induced by mRNA vaccination differs from natural SARS-CoV-2 infection

Study identifies how SARS-CoV-2 enters and infects the brain

Can an immunosuppressive cancer drug promote SARS-CoV-2 entry into host cells?

Could virosome-based nanovaccines be a promising new approach to preventing viral diseases?

Plant-derived compound isorhamnetin may have antiviral potential against SARS-CoV-2

Obesity, hypertension and smoking linked to lower vaccine-induced antibody production against SARS-CoV-2

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

Elderly patients of female physicians are more likely to be vaccinated against the flu

COVID-19 vaccination of lactating mothers elicits specific IgA antibodies in breast milk

Curcumin nanosystems could be powerful COVID-19 therapeutics

Obese or overweight patients at high risk for having worse COVID-19 outcomes

UGA receives NIH contract to establish the Center for Influenza Disease and Emergence Research

Researchers identify two distinct phenotypes of COVID-19-associated ARDS

Study observes neurological and psychiatric outcomes in recovered COVID-19 patients six months post-infection

Future attempts to reduce Covid-19 spread should focus on tackling airborne transmission

Allometric model shows human travel is closely related to spread of COVID-19

NIAID establishes a network of research sites to study influenza outbreaks

SARS-CoV-2 mutations impact T-cell recognition of virus

Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion

Alpaca nanobodies effective against South African SARS-CoV-2 variant

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Influenza News and Research

Latest Influenza News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in